Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07292233 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT07292233 |
| Lead Sponsor | Luye Pharma Group Ltd. |
| Conditions | Schizophrenia, Alzheimer's Disease Psychosis |
| Enrollment | 16 participants |
| Start Date | 2025-07-30 |
| Primary Completion | 2025-08-27 (estimated) |
| Study Completion | 2026-03-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-12-18 |